Skip to main content

JPMORGAN CHASE & CO

Position in ZVRA — Zevra Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in ZVRA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$3,531,645
-$162,212 QoQ
Shares Held
378,932
-8.1% QoQ
Ownership
0.641%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority Sole 86.88075960858413.ToString("F0")% Shared 0.ToString("F0")% None 13.119240391415874.ToString("F0")%

Common Shares in ZVRA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. ZVRA ranks #116 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZVRA

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,531,645 378,932
2025-12-31 $3,693,857 412,261
2025-09-30 $4,174,736 438,984
2025-06-30 $248,097 28,161
2025-03-31 $218,242 29,138
2024-12-31 $229,265 27,490
2024-09-30 $126,759 18,265
2024-06-30 $91,457 18,665
2024-03-31 $87,352 15,061
2023-12-31 $176,154 26,894
2023-09-30 $112,126 23,263
2023-06-30 $141,136 27,674
2023-03-31 $4,279 778
2022-12-31 $3,571 778
2022-09-30 $13,572 2,175
2022-06-30 $6,966 1,562
2022-03-31 $91,017 18,095
2021-12-31 $122,854 14,105
2021-09-30 $138,708 14,867
2021-06-30 $140,661 10,972